Lamotrigine Discontinuation Taper
Lamotrigine should be discontinued using a step-wise dose reduction over at least 2 weeks (approximately 50% dose reduction per week), unless safety concerns require more rapid withdrawal. [1] Abrupt discontinuation is not recommended because it can lead to uncontrolled seizures. [2]
Recommended Taper Schedule
- Reduce lamotrigine dose in a step-wise manner over at least 2 weeks. [1]
- Use an approximately 50% dose reduction per week approach during the discontinuation period. [1]
- Implement a more rapid withdrawal only when safety concerns require faster discontinuation. [1]
Initiation Thresholds for Slower vs Faster Withdrawal
- Faster withdrawal than the minimum 2-week taper is reserved for safety concerns that require more urgent discontinuation. [1]
- When no safety concern mandates urgency, the minimum taper duration of at least 2 weeks should be followed. [1]
Monitoring During Withdrawal
- Seizure recurrence during antiseizure medication withdrawal should be anticipated after dose reduction. [3]
- Seizure recurrence management requires clinical reassessment after antiseizure medication changes, including medication withdrawal decisions. [3]
Conversion and Cross-Taper Considerations
- If lamotrigine is being discontinued while transitioning to or from another antiseizure regimen, discontinuation should be coordinated with the overall switching plan. [4]
- Cross-taper schedules should be directed by prescriber guidance based on concomitant therapy and clinical indication. [4]
Medication Safety Precautions
- Lamotrigine should not be stopped abruptly without prescriber consultation. [2]
- Stopping lamotrigine can lead to uncontrolled seizures. [2]
Practical Example Taper (Illustrative)
- If the current total daily dose is 100 mg/day, an illustrative taper consistent with labeling would reduce to about 50 mg/day for one week, then to about 25 mg/day for the second week, followed by discontinuation after completion of the minimum 2-week period. [1]
- Exact dose increments should be adjusted to available tablet strengths and the prescriber’s taper plan. [1]
Target Outcomes of Tapering
The taper should aim to minimize seizure recurrence risk while completing discontinuation using the labeled step-wise reduction strategy. [1]